Driver mutation frequency

There is 1 paper on driver mutation frequency in aging research: 1 observational study in people.

Biomarker

1 paper studies it1 finding

See all 1

“neither mutation frequency (p=0.901), nor median tumour mutation burden (TMB) (2.27 vs 2.15 mut/Mb, p=0.242), in index adenomas was associated with the development of metachronous lesions”
Classical driver mutations are not associated with metachronous lesion risk in patients undergoing post-polypectomy surveillance following removal of conventional adenomas in a bowel screening settingmedRxiv2026doi:10.64898/2026.08.05.26359768
  • Humans1

Effects

1

Metachronous neoplasia

no changein humans1

1 study
  1. Driver mutation frequency was not clearly linked with metachronous neoplasia in index adenomas, after polypectomy with surveillance colonoscopy within 6 years (p=0.901).

    “neither mutation frequency (p=0.901), nor median tumour mutation burden (TMB) (2.27 vs 2.15 mut/Mb, p=0.242), in index adenomas was associated with the development of metachronous lesions”

    Humansin index adenomas, after polypectomy with surveillance colonoscopy within 6 yearscolorectal adenoma

    Classical driver mutations are not associated with metachronous lesion risk in patients undergoing post-polypectomy surveillance following removal of conventional adenomas in a bowel screening setting

    medRxivPreprint

More on Metachronous neoplasia

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 1Sep 2026: 0Oct 2026: 0Nov 2026: 01 paper in 12 months